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Abstract
PCR-based assays are the most sensitive and specific methods to detect malaria parasites.
This study compared the diagnostic accuracy of three PCR-based assays that do not only differ in
their sequence target, but also in the number of copies of their target region, for the detection of
Plasmodium falciparum in 401 individuals living in a malaria-endemic area in Nigeria. Compared to a
composite reference generated from results of all the 3 PCR assays, the stevor gene amplification
had a sensitivity of 100% (Kappa = 1; 95% CI = 1.000–1.000), 83% (Kappa = 0.718; 95% CI = 0.648–
0.788) by SSUrRNA gene PCR and 71% (Kappa = 0.552; 95% CI = 0.478–0.627) by the msa-2 gene
amplification.
Results from this study indicate that the stevor gene amplification is the most sensitive technique
for the detection of P. falciparum. This assay may be an important reference standard, especially
when a confirmatory technique with high sensitivity and specificity is needed for ruling out P.
falciparum infection.
Background
Prompt and accurate diagnosis is an important tool in the
effective management and control of malaria, a disease
which accounts for more than a million deaths annually
[1,2]. Microscopy remains the cheapest and most com-
monly used method for malaria diagnosis and relies on
the microscopic examination of stained blood films.
Microscopy, however, has its own limitations, even when
performed by an expert. It is time-consuming and its sen-
sitivity is limited, particularly when parasitaemia is low
[3]. Sensitivity and specificity are of crucial importance in
any identification method as a false negative result could
result in the non-treatment of a potentially fatal disease
and conversely a false positive result will expose individu-
als to unnecessary drug intake, with its associated side-
effects and high cost, while leaving the true cause of the ill-
ness untreated. Misdiagnosis of malaria, however, could
have fatal consequences [4]. It is, therefore, important that
a reliable, rapid and efficient method for diagnosis, sur-
veillance and epidemiological studies is identified.
Several new diagnostic techniques have been developed
during the last decade, including antigen detection and
fluorescence-based assays, which have the added advan-
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tage of moving the diagnosis of malaria nearer to the
patient and even faster [5,6]. These, also have drawbacks
as their sensitivity decreases especially with low parasitae-
mia or they may have variability in performance: misdiag-
nosis with such methods have been reported [7-11].
PCR-based assays have been used in diagnosis and as ref-
erence or standard for the assessment of the sensitivity
and specificity of microscopy and commonly deployed
rapid diagnostic tests and may indeed, be of clinical value
in some selected situations [12-17]. Examples include: the
PCR of stevor gene, a multiple copy sequence of the subte-
lomeric variable open reading frame of Plasmodium falci-
parum which were used in detection or measurement of
very low parasitaemia [18,19]; the genus and species-spe-
cific PCR, which was designed to amplify portions of the
sequences coding for the small subunit ribosomal RNA
(SSUrRNA) and has the added advantage of being able to
detect all the four species of human Plasmodium, as well as
the quantification of P. falciparum [20,21]; and, the PCR
typing of highly polymorphic merozoite surface antigens
of  P. falciparum, which has been particularly useful in
determining genetic variability of parasite isolates [22]
and in detection of microscopically undetected parasites
in drug trials [23].
Despite the fact that PCR-based assays are meant to be
highly sensitive, it is not known whether this sensitivity is
equally good with all amplification techniques in use and
high enough to justify their use as reference or standard in
the diagnosis of P. falciparum infection. In this study, the
sensitivity and specificity of three different PCR assays
with target to mono- or multi-copy gene for the detection
of P. falciparum were assessed.
Methods
Study site and sample collection
This study was conducted in Lafia, located within the
Guinea savanna ecological zone in north-central Nigeria.
Within this region, malaria transmission has formerly
been described as stable and uniformly intense through
most of the year [24,25]. 401 children between 6 months
and 8 years of age, from amongst those who reported for
routine medical examination on complaint of fever, were
enrolled into the study at the Dalhatu Araf Specialist Hos-
pital (DASH), Lafia between November, 2005 and July,
2006. Informed consent was obtained from the parent or
guardian of each child prior to being included in the
study. Ethical approval for the study was granted by the
Ethical Review Committees of the Nasarawa State Minis-
try of Health and the Dalhatu Araf Specialist Hospital,
Lafia. Inclusion criteria are febrile conditions suggestive of
malaria which includes chills, history of fever within the
preceding 48 h or pyrexia at presentation (axillary temper-
ature >37.5°C), or fever of unknown aetiology. Children
with signs or symptoms of severe illness were excluded
from the study.
Finger-prick blood samples were collected for thick and
thin blood smear and on filter paper for PCR. Two drops
of blood were spotted on each filter paper, air dried and
individually sealed in plastic bags and stored at room tem-
perature until DNA extraction. Giemsa-stained thick and
thin blood films were examined for malaria parasites. Par-
asitaemia were quantified relative to 250 white blood cells
(WBC) on thick films and estimated as parasites per μl
assuming a mean WBC of 8,000 per μl of blood. Blood
smears were labeled negative if no parasites were seen
after examination of 200 oil immersion fields (×1,000) on
a thick blood film.
DNA extraction and PCR
DNA was extracted from the dried blood spots on filter
paper using the QIAamp® DNA Mini Kit (Qiagen, Hilden,
Germany) following the manufacturer's protocol, and
stored at -20°C until further analysis. 150 μl of distilled
water was used to elute DNA. All PCR assays include a pri-
mary and nested reaction to enhance specificity. Amplifi-
cation was performed using a BIOMETRA TB1 thermal
cycler (Biotron, Göttingen Germany).
SSUrRNA gene PCR
In all reaction, 2.0 μl of DNA extract were amplified in a
final volume of 25 μl containing 2.5 μl ×10 reaction
buffer, 100 μM of each dNTPs (dATP, dGTP, dTTP, and
dCTP), 0.5 pM of each primer (rPLU5/rPLU6 for the pri-
mary reaction and rFAL1/rFAL2 for the nested reaction)
and 0.75 units of Taq DNA polymerase (Qiagen, Hilden,
Germany). Primer sequences (Table 1) are based on the
SSUrRNA sequences described elsewhere [26]. The PCR
programme was: denaturation at 95°C for 5 min followed
by 25 cycles (30 cycles in nested) of 1 min at 94°C, 2 min
at 60°C and 2 min at 72°C and a final extension period
of 5 min at 72°C.
stevor gene PCR
Primary amplification was performed with reaction mix-
ture of 50 μl containing 5.0 μl ×10 reaction buffer, 200
μM of each dNTPs (dATP, dGTP, dTTP, and dCTP), 1.25
units of Taq DNA polymerase, 0.4 pM of each primer (P5,
P18, P19 and P20) and 5.0 μl of DNA extract. The PCR
programme was: denaturation at 93°C for 3 min followed
by 25 cycles of 30 sec at 93°C, 50 sec at 50°C and 30 sec
at 72°C and a final extension period of 3 min at 72°C. 2.0
μl of the first-round PCR product was used in the second
round amplification which was performed with a reaction
mixture of 50 μl containing 5.0 μl ×10 reaction buffer, 200
μM of each dNTPs, 1.25 units of Taq DNA polymerase and
0.4 pM of each primer (P17 and P24). The primer
sequences for the stevor PCR are shown in Table 1. PCRMalaria Journal 2007, 6:112 http://www.malariajournal.com/content/6/1/112
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conditions for the nested reaction was: denaturation at
93°C for 3 sec followed by 25 cycles of 30 sec at 93°C, 50
sec at 55°C and 30 sec at 72°C and a final extension
period of 3 min at 72°C.
msa-2 gene PCR
The primary reaction was designed to amplify the entire
coding region of the msa-2 gene using the msa-2-1 and
msa-2-4 primers pairs (Table 1). The reaction mixture was
performed in a final volume of 50 μl containing 5.0 μl of
DNA extract, 5.0 μl ×10 reaction buffer, 200 μM of each
dNTPs (dATP, dGTP, dTTP, and dCTP), 1.25 units of Taq
DNA polymerase and 0.5 pM of each primer. The PCR
programme was: denaturation at 94°C for 5 min followed
by 35 cycles of 10 sec at 94°C, 30 sec at 57°C and 40 sec
at 72°C and a final extension period of 3 min at 72°C.
This was followed by two sets of nested reactions using
allelic family-specific primers (FC27 and 3D7). A third
reaction was performed to amplify the entire central vari-
able region with the primer pairs msa-2-2 and msa-2-3
(Table 1), in order to detect sequences that may not be
allelic family-specific. All nested reactions were performed
in a final volume of 50 μl containing 2.0 μl of PCR prod-
uct from primary reaction, 5.0 μl ×10 reaction buffer, 200
μM of each dNTPs, 0.5 pM of each primer and 1.25 units
of Taq DNA polymerase. The PCR programme was: dena-
turation at 94°C for 5 sec followed by 30 cycles of 10 sec
at 94°C, 30 sec at 57°C and 40 sec at 72°C and a final
extension period of 3 min at 72°C.
PCR products were subjected to electrophoresis on 1.5–
2% agarose gels and visualized by transillumination with
ultraviolet light after staining with SYBR® Green. Fragment
sizes were calculated relative to the standard size marker
(100 bp DNA ladder) using the BioDocAnalyze (Biome-
tra, Göttingen, Germany) computer software package.
All reactions were run in parallel with DNA from negative
controls (non-exposed European samples) confirmed
negative by the three PCR assays, and DNA from FCR-3
and 3D7 strains as positive controls. This strategy was
used to enhance specificity and to ensure that the reaction
does not spuriously amplify homologous sequences. For
a reaction to remain valid, all negative controls in a run
must remain negative while the positive controls must
remain positive.
Statistical analysis
Data were entered into SPSS for Windows software pack-
age, version 11.0.0 (SPSS Inc., 2001). Sensitivity, specifi-
city and Cohen's kappa coefficient (κ) with their 95%
confidence intervals (CI) were determined using Stata ver-
sion 9.2 (StataCorp, College Station, Texas). Cohen's
kappa coefficient is a measure of the agreement between
two tests beyond that expected by chance, where 0 is
chance agreement and 1 is perfect agreement [27].
Results
Among the 401 children enrolled in this study, 169 pre-
sented with microscopically confirmed P. falciparum. The
mean (± SD) age and weight of the children were 40.4 (±
19.2) months and 13.6 (± 3.1) Kg respectively. The base-
line characteristics of the study children are shown in
Table 2. A composite reference was generated and used as
Table 1: Nucleotide sequence of primers used in this study
Primer Name Nucleotide sequence
rPLU5 5'-CCT GTT GTT GCC TTA AAC TTC-3'
rPLU6 5'-TTA AAA TTG TTG CAG TTA AAA CG-3'
rFAL 1 5'-TTA AAC TGG TTT GGG AAA ACC AAA TAT ATT-3'
rFAL 2 5'-ACA CAA TGA ACT CAA TCA TGA CTA CCC GTC-3'
P5 5'-GGG AAT TCT TTA TTT GAT GAA GAT G-3'
P18 5'-TTT CA(C/T) CAC CAA ACA TTT CTT-3'
P19 5'-AAT CCA CAT TAT CAC AAT GA-3'
P20 5'-CCG ATT TTA ACA TAA TAT GA-3'
P17 5'-ACA TTA TCA TAA TGA (C/T) CC AGA ACT-3'
P24 5'-GTT TGC AAT AAT TCT TTT TCT AGC-3'
MSA 2-1 5'-ATG AAG GTA ATT AAA ACA TTG TCT ATT ATA-3'
MSA 2-4 5'-TTA TAT GAA TAT GGC AAA AGA TAA AAC AAG-3'
MSA 2-2 5'-ACA TTC ATA AAC AAT GCT TAT AAT ATG AGT-3'
MSA 2-3 5'-GAT TAT TTC TAG AAC CAT GCA TAT GTC CAT-3'
FC 27-1 5'-GCA AAT GAA GGT TCT AAT ACT AAT AG-3'
FC 27-2 5'-GCT TTG GGT CCT TCT TCA GTT GAT TC-3'
3D7-1 5'-GCA GAA AGT AAG CCT TCT ACT GGT GCT-3'
3D7-2 5'-GAT TTG TTT CGG CAT TAT TAT GA-3'Malaria Journal 2007, 6:112 http://www.malariajournal.com/content/6/1/112
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the gold standard to assess the sensitivity of each PCR
assay. This was defined as a positive test by at least one of
the three PCR assays relative to the positive and negative
controls. This method was adopted in order to avoid
errors in measuring the sensitivity of the techniques if a
particular assay was chosen as the "gold standard" when it
does not have 100% sensitivity. Sensitivity was defined as
the probability that a truly infected individual will test
positive and was assessed relative to the FCR-3 and 3D7
strains as positive controls. Specificity was defined as the
probability that a truly uninfected individual will test neg-
ative and was assessed in 86 unexposed European sam-
ples.
A total of 285 patients were detected to be infected with P.
falciparum  by the composite reference. Cohen's kappa
coefficient showed that the stevor  PCR has a complete
agreement with the composite reference having a Kappa
(95%CI) of 1.00 (1.000–1.000), followed by the SSUr-
RNA PCR κ = 0.718 (0.648–0.788) and the msa-2 PCR κ =
0.552 (0.478–0.627). The results of the detection of P. fal-
ciparum by the three PCR assays are shown in Table 3. All
the 86 unexposed European samples tested negative with
the three PCR assays thus, implying 100% specificity
(Table 3). The specificity of microscopy could not be
determined from the unexposed European samples
because their slides were not available for microscopy.
To determine reproducibility, all samples that did not
show identical result with the three PCR techniques were
classified as discordant and were re-amplified. In all, 84
samples were re-examined and the PCR results obtained
were 100% reproducible.
The diagnostic accuracy of the stevor PCR was significantly
different to the other two PCR assays (P < 0.001) and, like-
wise, that of the SSUrRNA PCR was significantly different
from the msa-2 PCR (P < 0.001).
Discussion
Routine microscopic examination of Giemsa-stained
blood smears is usually considered as the gold standard
for malaria diagnosis. However, this technique requires
highly skilled personnel and the information obtained by
microscopy is limited when parasite levels are very low or
when parasite morphology is altered. This has prompted
the development of rapid diagnostic assays based on the
detection of parasite antigens in whole blood and DNA
based methods for the detection of parasites, mainly the
clinically important P. falciparum infection. Rapid diag-
nostic tests, however, have low sensitivity at parasitaemia
below 100 parasites/μl and have insufficient accuracy
(Rubio, 2001).
PCR-based methods have been consistently shown to be
powerful tool for malaria diagnosis [28-31]. Despite the
fact that PCR-based assays have better sensitivity than
conventional microscopy and antigen-based diagnostic
tests [32], observations from this study show that their
level of sensitivity could vary depending on the approach
employed and the characteristic of the target sequence of
the chosen assay. In this study, the stevor PCR was found
to have the highest sensitivity for detecting P. falciparum,
Table 2: Baseline characteristics of children enrolled into the study
Number of subjects 401
Mean age (months) 40.4 (± 19.2)*
Sex (male/female) 203/198
Mean temperature (°C) 38.4 (± 1.2)*
Mean haematocrit (%) 28 (± 3.1)*
Mean weight (Kg) 13.1 (± 3.2)*
% positive by microscopy 42.1% (169/401)
% positive by stevor PCR 71.1% (285/401)
% positive by SSUrRNA PCR 59.1% (237/401)
% positive by msa-2 PCR 50.1% (201/401)
* ± Standard deviation in parentheses
Table 3: Sensitivity of the PCR-based assays for the detection of P. falciparum
stevor PCR SSUrRNA PCR msa-2 PCR
Sensitivity 100% 83% 71%
Specificity 100% 100% 100%
Correctly classified 100% 87.2% 77.6%
Agreement (Kappa)a, b 1.00 (1.000–1.000) 0.718 (0.648–0.788) 0.552 (0.478–0.627)
aComposite reference compared with study assay; Kappa = 1 would indicate complete agreement.
b95% confidence intervals in parentheses.Malaria Journal 2007, 6:112 http://www.malariajournal.com/content/6/1/112
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with 100% sensitivity and could correctly classify 100% of
the population. This was followed by the SSUrRNA PCR
with a sensitivity of 83% and could correctly classify 87%
of the population, and then the msa-2 gene PCR with 71%
sensitivity and could correctly classify 78% of the study
population. Differences in sensitivity could thus, be corre-
lated with the copy number of the amplified region
although, sequence variations in target region of primers
used might be a contributing factor. The stevor-based PCR
is therefore, at a vantage position since it was designed to
amplify fragments of a gene that has between 30 to 40
copies per haploid genome [33,34] compared to the SSUr-
RNA  gene which has about four copies per haploid
genome [35,36] or the msa-2 gene which is a single copy
gene [37,38].
One limitation of this study though, is that it focuses on
P. falciparum infections and does not address other species
of human Plasmodium. However, P. falciparum demands
particular attention because, it is the species of human
malaria parasite that causes the most severe form of the
disease and can kill with stunning speed.
Conclusion
Despite having higher sensitivity and specificity in detect-
ing  Plasmodium  infections, the use of PCR-based tech-
niques in routine diagnosis is limited because of their
logistical and technical difficulties [15]. They are labour-
intensive and costly to maintain. However, PCR assays are
invaluable tool in reference laboratories where quality
assurance is required and, for public health surveillance in
detecting submicroscopic asymptomatic infections. They
could be particularly important in critical situations
where a confirmatory assay with high sensitivity and spe-
cificity is needed for ruling out P. falciparum infection
especially in non-immune travellers. The level of sensitiv-
ity of an assay though, could vary depending on the char-
acteristics of the target sequence and the approach
employed. This study shows that PCR assays with target to
multiple copy sequences are more sensitive, the larger the
copy number. As the scale of field studies grow, PCR diag-
nosis of malaria will play an increasing role in epidemiol-
ogy with the development of high-throughput techniques
that could facilitate large-scale analysis of samples within
a short period.
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